4D pharma PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
31,830.00
85,441.00
68,772.00
49,998.00
26,227
Total Accounts Receivable
234.00
2,623.00
3,315.00
4,308.00
5,393
Inventories
115.00
28.00
238.00
253.00
290
Other Current Assets
356.00
2,013.00
2,651.00
3,238.00
1,248
Total Current Assets
32,535.00
90,105.00
74,976.00
57,797.00
33,158
Net Property, Plant & Equipment
417.00
1,115.00
3,859.00
5,211.00
4,865
Long-Term Note Receivable
-
-
23.00
-
-
Intangible Assets
6,266.00
6,171.00
14,299.00
14,674.00
14,445
Other Assets
-
-
-
56.00
137
Total Assets
39,218.00
97,391.00
93,157.00
77,738.00
52,605
ST Debt & Current Portion LT Debt
-
-
-
10.00
Accounts Payable
1,375.00
2,891.00
1,163.00
1,803.00
Other Current Liabilities
410.00
1,418.00
3,774.00
3,169.00
Total Current Liabilities
1,785.00
4,309.00
4,937.00
4,982.00
Long-Term Debt
-
-
-
26.00
Deferred Taxes
385.00
385.00
963.00
965.00
Other Liabilities
-
-
774.00
1,979.00
Total Liabilities
2,170.00
4,694.00
6,674.00
7,952.00
Common Equity (Total)
37,326.00
92,697.00
86,483.00
69,786.00
Total Shareholders' Equity
37,326.00
92,697.00
86,483.00
69,786.00
Total Equity
37,048.00
92,697.00
86,483.00
69,786.00
Liabilities & Shareholders' Equity
39,218.00
97,391.00
93,157.00
77,738.00
Accumulated Minority Interest
278.00
-
-
-

About 4D pharma

View Profile
Address
9 Bond Court
Leeds Yorkshire LS1 2JZ
United Kingdom
Employees -
Website http://4dpharmaplc.com
Updated 07/08/2019
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of MicroRx, its proprietary platform for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded on January 10, 2014 and is headquartered in Leeds, the United Kingdom.